TMCnet News
Research and Markets: Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/j35z9p/mild_cognitive) has announced the addition of the "Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014" report to their offering. Our clinical trial report, Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014" provides data on the Mild Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preiminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/j35z9p/mild_cognitive
|